Intensive Care Medicine最新文献

筛选
英文 中文
Delirium prevention requires more than melatonin: insights from the DEMEL trial. 预防谵妄需要的不仅仅是褪黑素:来自DEMEL试验的见解。
IF 21.2 1区 医学
Intensive Care Medicine Pub Date : 2025-08-19 DOI: 10.1007/s00134-025-08076-9
Flávia Gabe Beltrami, Laura Drehmer, Regis Goulart Rosa, Cassiano Teixeira, Felippe Leopoldo Dexheimer Neto
{"title":"Delirium prevention requires more than melatonin: insights from the DEMEL trial.","authors":"Flávia Gabe Beltrami, Laura Drehmer, Regis Goulart Rosa, Cassiano Teixeira, Felippe Leopoldo Dexheimer Neto","doi":"10.1007/s00134-025-08076-9","DOIUrl":"10.1007/s00134-025-08076-9","url":null,"abstract":"","PeriodicalId":13665,"journal":{"name":"Intensive Care Medicine","volume":" ","pages":""},"PeriodicalIF":21.2,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144873056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
European Society of Intensive Care Medicine Clinical Practice Guideline on fluid therapy in adult critically ill patients: Part 3-fluid removal at de-escalation phase. 欧洲重症监护医学学会成人危重病人液体治疗临床实践指南:第3部分:缓解期液体清除
IF 21.2 1区 医学
Intensive Care Medicine Pub Date : 2025-08-19 DOI: 10.1007/s00134-025-08058-x
Marlies Ostermann, Fayez Alshamsi, Antonio Artigas Raventos, Maurizio Cecconi, Carole Ichai, Christina Jones, Manu L N G Malbrain, Xavier Monnet, Marek Nalos, Zhiyong Peng, Carmen A Pfortmueller, John Prowle, Otavio Ranzani, Manu Shankar-Hari, Adrian Wong, Morten Hylander Møller, Daniel De Backer
{"title":"European Society of Intensive Care Medicine Clinical Practice Guideline on fluid therapy in adult critically ill patients: Part 3-fluid removal at de-escalation phase.","authors":"Marlies Ostermann, Fayez Alshamsi, Antonio Artigas Raventos, Maurizio Cecconi, Carole Ichai, Christina Jones, Manu L N G Malbrain, Xavier Monnet, Marek Nalos, Zhiyong Peng, Carmen A Pfortmueller, John Prowle, Otavio Ranzani, Manu Shankar-Hari, Adrian Wong, Morten Hylander Møller, Daniel De Backer","doi":"10.1007/s00134-025-08058-x","DOIUrl":"10.1007/s00134-025-08058-x","url":null,"abstract":"<p><strong>Purpose: </strong>This is the third of three parts of the clinical practice guideline from the European Society of Intensive Care Medicine (ESICM) on fluid management in adult critically ill patients. This part addresses fluid removal in the de-escalation phase of shock management.</p><p><strong>Methods: </strong>This guideline was formulated by an international panel of clinical experts, methodologists, and patient representatives. A literature search was conducted to identify relevant randomized controlled trials (RCTs) in adults published up to February 2025. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology was applied to evaluate the certainty of evidence and to move from evidence to decision.</p><p><strong>Results: </strong>Based on data from 13 RCTs, the panel issued three conditional recommendations. The panel suggested de-escalation of fluid therapy over no de-escalation in critically ill adults after the acute phase of fluid resuscitation (low certainty evidence). They suggested protocolized fluid removal by diuretics over usual care in critically ill patients after the acute phase of fluid resuscitation (moderate certainty evidence). A conditional recommendation was issued against the routine use of ultrafiltration or extracorporeal fluid removal in critically ill adults after the acute phase of fluid resuscitation, without other indication for RRT (low certainty evidence). There was limited evidence to comment on fluid removal in specific patient cohorts.</p><p><strong>Conclusions: </strong>This ESICM guideline provides three recommendations to inform clinicians on fluid removal during the de-escalation phase in critically ill patients with shock who no longer need fluid resuscitation.</p>","PeriodicalId":13665,"journal":{"name":"Intensive Care Medicine","volume":" ","pages":""},"PeriodicalIF":21.2,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144873058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How we use critical care ultrasonography in the management of cardiogenic shock: a strategic game of chess in intensive care. 重症监护超声在心源性休克治疗中的应用:重症监护的战略棋局。
IF 38.9 1区 医学
Intensive Care Medicine Pub Date : 2025-08-14 DOI: 10.1007/s00134-025-08048-z
Filippo Sanfilippo,Siddharth Dugar,Michelle S Chew
{"title":"How we use critical care ultrasonography in the management of cardiogenic shock: a strategic game of chess in intensive care.","authors":"Filippo Sanfilippo,Siddharth Dugar,Michelle S Chew","doi":"10.1007/s00134-025-08048-z","DOIUrl":"https://doi.org/10.1007/s00134-025-08048-z","url":null,"abstract":"","PeriodicalId":13665,"journal":{"name":"Intensive Care Medicine","volume":"37 1","pages":""},"PeriodicalIF":38.9,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144851206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meropenem and piperacillin/tazobactam optimised dosing regimens for critically ill patients receiving renal replacement therapy. 美罗培南和哌拉西林/他唑巴坦优化了危重患者接受肾脏替代治疗的给药方案。
IF 38.9 1区 医学
Intensive Care Medicine Pub Date : 2025-08-13 DOI: 10.1007/s00134-025-08067-w
Jason A Roberts,Marta Ulldemolins,Xin Liu,João P Baptista,Irma Bilgrami,Clement Boidin,Alexander Brinkmann,Pedro Castro,Gordon Choi,Louise Cole,Jan J De Waele,Renae Deans,Sine Donnellan,Glenn M Eastwood,Otto R Frey,Sylvain Goutelle,Rebecca Gresham,Janattul Ain Jamal,Gavin M Joynt,Salmaan Kanji,Stefan Kluge,Christina König,Vasilios P Koulouras,Melissa Lassig-Smith,Pierre-Francois Laterre,Anna Lee,Jean-Yves Lefrant,Katie Lei,Patricia Leung,Mireia Llaurado-Serra,Ignacio Martin-Loeches,Mohd Basri Mat Nor,Yugan Mudaliar,Marlies Ostermann,Sanjoy K Paul,Sandra L Peake,Jordi Rello,Darren M Roberts,Michael S Roberts,Brent Richards,Alejandro Rodríguez,Anka C Roehr,Claire Roger,Leonardo Seoane,Mahipal Sinnollareddy,Eduardo Sousa,Dolors Soy,Anna Spring,Therese Starr,Dianne Stephens,Fabio Silvio Taccone,Jane Thomas,John Turnidge,Miia Valkonen,Julie M Varghese,Steven C Wallis,Robert J Walker,Tricia Williams,Luke C Wilson,Xavier Wittebole,Daniel F B Wright,Xanthi T Zikou,Rinaldo Bellomo,Jeffrey Lipman,
{"title":"Meropenem and piperacillin/tazobactam optimised dosing regimens for critically ill patients receiving renal replacement therapy.","authors":"Jason A Roberts,Marta Ulldemolins,Xin Liu,João P Baptista,Irma Bilgrami,Clement Boidin,Alexander Brinkmann,Pedro Castro,Gordon Choi,Louise Cole,Jan J De Waele,Renae Deans,Sine Donnellan,Glenn M Eastwood,Otto R Frey,Sylvain Goutelle,Rebecca Gresham,Janattul Ain Jamal,Gavin M Joynt,Salmaan Kanji,Stefan Kluge,Christina König,Vasilios P Koulouras,Melissa Lassig-Smith,Pierre-Francois Laterre,Anna Lee,Jean-Yves Lefrant,Katie Lei,Patricia Leung,Mireia Llaurado-Serra,Ignacio Martin-Loeches,Mohd Basri Mat Nor,Yugan Mudaliar,Marlies Ostermann,Sanjoy K Paul,Sandra L Peake,Jordi Rello,Darren M Roberts,Michael S Roberts,Brent Richards,Alejandro Rodríguez,Anka C Roehr,Claire Roger,Leonardo Seoane,Mahipal Sinnollareddy,Eduardo Sousa,Dolors Soy,Anna Spring,Therese Starr,Dianne Stephens,Fabio Silvio Taccone,Jane Thomas,John Turnidge,Miia Valkonen,Julie M Varghese,Steven C Wallis,Robert J Walker,Tricia Williams,Luke C Wilson,Xavier Wittebole,Daniel F B Wright,Xanthi T Zikou,Rinaldo Bellomo,Jeffrey Lipman, ","doi":"10.1007/s00134-025-08067-w","DOIUrl":"https://doi.org/10.1007/s00134-025-08067-w","url":null,"abstract":"PURPOSEOptimal dosing of meropenem and piperacillin/tazobactam in critically ill patients receiving renal replacement therapy (RRT) is uncertain due to variable pharmacokinetics. We aimed to develop generalisable optimised dosing recommendations for these antibiotics.METHODSProspective, multinational pharmacokinetic study including patients requiring various forms of RRT. Independent population PK models were developed, externally validated and applied to perform Monte Carlo dosing simulations using Monolix and Simulx. We calculated the probability that these dosing regimens achieved standard and high therapeutic unbound antibiotic concentrations over 100% of the dosing interval for the treatment of Enterobacterales and Pseudomonas aeruginosa.RESULTSWe enrolled 300 patients from 22 intensive care units across 12 countries receiving continuous veno-venous haemodialysis (13.0%), haemofiltration (23.3%), haemodiafiltration (48.4%) or sustained low-efficiency dialysis (15.3%). Models were developed using data from 234 patients (8322 samples) and validated with 66 additional patients (560 samples). Predictive performance was high, with mean prediction errors of - 5.2% for meropenem and - 16.9% for piperacillin. Dosing simulations showed that meropenem and piperacillin/tazobactam dosing requirements were dependent on urine output and RRT intensity and duration (p < 0.05). In all scenarios, extended/continuous infusions led to a better achievement of effective concentrations with lower daily doses compared to short infusion. Dosing nomograms were developed to inform dosing for different RRT settings, urine outputs, and target concentrations.CONCLUSIONRRT intensity and duration and urine output determine meropenem and piperacillin/tazobactam dosing requirements in critically ill patients receiving RRT. Extended/continuous infusions facilitate the attainment of effective concentrations.","PeriodicalId":13665,"journal":{"name":"Intensive Care Medicine","volume":"7 1","pages":""},"PeriodicalIF":38.9,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144825884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hemodynamic and neurological presentations of invasive meningococcal disease in adults: a nationwide study across 100+ French ICUs : The RETRO-MENINGO study. 成人侵袭性脑膜炎球菌病的血液动力学和神经学表现:一项覆盖100多个法国icu的全国性研究:retroo - meningo研究
IF 38.9 1区 医学
Intensive Care Medicine Pub Date : 2025-08-12 DOI: 10.1007/s00134-025-08043-4
Damien Contou,Benoit Painvin,Delphine Daubin,Arthur Orieux,Hugo Pirollet,Martin Cour,Benjamine Sarton,Marie Gauvrit,Mathilde Taillantou-Candau,Paola Lepoutre,Guillaume Louis,Fabrice Bruneel,Christelle Teiten,Maud Vincendeau,Marion Giry,François Legay,Rémi Coudroy,Olivier Puig,Pierre Bay,Guillaume Schnell,Geoffrey Ledoux,Romain Sonneville,Danielle Reuter,Xavier Valette,Piotr Szychowiak,Nicolas Dufour,Tomas Urbina,Gaëtan Plantefève,Nicolas de Prost,
{"title":"Hemodynamic and neurological presentations of invasive meningococcal disease in adults: a nationwide study across 100+ French ICUs : The RETRO-MENINGO study.","authors":"Damien Contou,Benoit Painvin,Delphine Daubin,Arthur Orieux,Hugo Pirollet,Martin Cour,Benjamine Sarton,Marie Gauvrit,Mathilde Taillantou-Candau,Paola Lepoutre,Guillaume Louis,Fabrice Bruneel,Christelle Teiten,Maud Vincendeau,Marion Giry,François Legay,Rémi Coudroy,Olivier Puig,Pierre Bay,Guillaume Schnell,Geoffrey Ledoux,Romain Sonneville,Danielle Reuter,Xavier Valette,Piotr Szychowiak,Nicolas Dufour,Tomas Urbina,Gaëtan Plantefève,Nicolas de Prost, ","doi":"10.1007/s00134-025-08043-4","DOIUrl":"https://doi.org/10.1007/s00134-025-08043-4","url":null,"abstract":"PURPOSEInvasive meningococcal disease (IMD) is a rare but potentially fatal infection caused by Neisseria meningitidis. In adults requiring admission to intensive care unit (ICU), IMD typically presents with two distinct clinical presentations: neurological (meningitis) and hemodynamic (sepsis). These presentations are often conflated, despite the differences in pathophysiology and outcome.METHODSRETRO-MENINGO is a nationwide, multicentre, retrospective cohort study conducted in 102 French ICUs between January 1, 2016, and December 31, 2024. Adults (≥ 18 years) admitted to the ICU with a microbiologically confirmed IMD were categorised as having either a neurological or a hemodynamic presentation according to the main reason for ICU admission. The primary outcome was day-60 mortality in each presentation.RESULTSOf 654 patients (median age 33 years [IQR 21-56]; 63.5% without comorbidities), 407 (62%) had a neurological and 247 (38%) a hemodynamic presentation at ICU admission. Hemodynamic presentation was associated with older age (39.0 vs. 30.0 years; p = 0.001), immunosuppression (17.0% vs. 7.1%; p < 0.001), purpuric rash (55.9% vs. 43.7%; p = 0.003), earlier ICU admission (1 vs. 2 days; p = 0.001) and more frequent bacteremia (83.8% vs. 35.6%; p < 0.001). Serogroup B was predominant in neurological presentation, whereas serogroup W135 was more common in hemodynamic presentation. Compared to neurological presentation, hemodynamic presentation required more organ support (vasopressors, invasive mechanical ventilation, transfusions, renal replacement therapy) and had a significantly higher day-60 mortality (25.5% vs. 4.7%; p < 0.001). Hemodynamic presentation (aOR 4.33, 95% CI 2.26-8.62; p < 0.001), absence of comorbidities (aOR 2.21, 95% CI 1.19-4.23; p = 0.014), age > 35 years (aOR 3.65, 95% CI 1.73-6.07; p < 0.001), arterial lactate level > 5 mmol/L (aOR 2.60, 95% CI 1.43-4.77; p = 0.002) and symptom onset < 24 h (aOR 1.90, 95% CI 1.00-3.55; p = 0.040) were independently associated with day-60 mortality, while early administration of a parenteral third-generation cephalosporin prior to ICU admission was strongly protective (aOR 0.31, 95% CI 0.18-0.55; p < 0.001).CONCLUSIONNeurological and hemodynamic presentation of IMD are clinically and prognostically distinct. Recognition of these phenotypes is critical for appropriate management and prediction of outcome.","PeriodicalId":13665,"journal":{"name":"Intensive Care Medicine","volume":"31 1","pages":""},"PeriodicalIF":38.9,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144819643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2D- and 3D-EIT are different, but which one is correct? 2D- eit和3D-EIT是不同的,但哪一个是正确的?
IF 38.9 1区 医学
Intensive Care Medicine Pub Date : 2025-08-12 DOI: 10.1007/s00134-025-08069-8
Ling Sang,Rui Zhang,Meng Dai,Junhong Jiang,Lin Yang
{"title":"2D- and 3D-EIT are different, but which one is correct?","authors":"Ling Sang,Rui Zhang,Meng Dai,Junhong Jiang,Lin Yang","doi":"10.1007/s00134-025-08069-8","DOIUrl":"https://doi.org/10.1007/s00134-025-08069-8","url":null,"abstract":"","PeriodicalId":13665,"journal":{"name":"Intensive Care Medicine","volume":"291 1","pages":""},"PeriodicalIF":38.9,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144819644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What measures have been used to explore the outcomes of family members of critically ill patients: a scoping review. 使用了哪些措施来探索危重患者家庭成员的结果:范围审查。
IF 38.9 1区 医学
Intensive Care Medicine Pub Date : 2025-08-12 DOI: 10.1007/s00134-025-08072-z
Claire Brown,Peter Hartley,Faye Forsyth,Leanne M Boehm,Graham Martin,Isla Kuhn,Natalie Pattison,Bronwen Connolly,Nazir Lone,Valerie Danesh,Joanne McPeake
{"title":"What measures have been used to explore the outcomes of family members of critically ill patients: a scoping review.","authors":"Claire Brown,Peter Hartley,Faye Forsyth,Leanne M Boehm,Graham Martin,Isla Kuhn,Natalie Pattison,Bronwen Connolly,Nazir Lone,Valerie Danesh,Joanne McPeake","doi":"10.1007/s00134-025-08072-z","DOIUrl":"https://doi.org/10.1007/s00134-025-08072-z","url":null,"abstract":"BACKGROUNDFamily members of critically ill patients are known to experience short and longer term challenges, including emotional and social problems. To undertake robust future interventional research to support this cohort, we undertook a comprehensive evaluation of the measures used in family outcome research to date.DESIGNScoping review. We searched Medline, PsycINFO, Scopus, CINAHL, and Web of Science (core collection) for articles published between 2000 and 2024 which examined the outcomes of family members of critically ill patients. Data on outcome measures, study design, and population characteristics were extracted from eligible studies.RESULTSWe reviewed 9873 abstracts and identified 388 eligible unique family member cohorts. Across these studies, there were 59 (15.2%) randomised control trials, 287 (74.0%) observational cohorts, 8 (2.1%) quality improvement programmes, and 34 (8.8%) non-randomised controlled interventional studies. Most research was undertaken in USA, Canada, and Europe (n = 264, 67.5%). A total of 218 different outcomes measures were used across the studies included. In this review, 345 (89%) studies measured emotional or psychological outcomes, 85 (22%) measured family experience outcomes, 65 (17%) measured general functional status, quality of life or well-being outcomes, 35 (9%) measured environmental or social outcomes, and 10 (3%) measured cognitive outcomes.CONCLUSIONSWe identified 388 studies which reported the outcomes of family members of critically ill patients. Over 200 different outcomes measures were utilised, exploring conceptual domains such as quality of life as well as psychological and social outcomes. The majority of studies were observational in nature with variable follow-up timelines. This review has highlighted that a core outcome measure set is essential to enable reliable, robust, and comparable interventional research in this area.","PeriodicalId":13665,"journal":{"name":"Intensive Care Medicine","volume":"13 1","pages":""},"PeriodicalIF":38.9,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144819645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Maintaining very low tidal volume ventilation with PEEP during CPB in cardiac surgery patients: are HLA-DR, IL-6, and MDSCs relatively accurately mirror the relationship between atelectasis and immune dysfunction? 心脏手术患者CPB期间使用PEEP维持极低潮气量通气:HLA-DR、IL-6和MDSCs是否相对准确地反映了肺不张与免疫功能障碍之间的关系?
IF 38.9 1区 医学
Intensive Care Medicine Pub Date : 2025-08-12 DOI: 10.1007/s00134-025-08075-w
Lei Zuo,Jinwen Ni
{"title":"Maintaining very low tidal volume ventilation with PEEP during CPB in cardiac surgery patients: are HLA-DR, IL-6, and MDSCs relatively accurately mirror the relationship between atelectasis and immune dysfunction?","authors":"Lei Zuo,Jinwen Ni","doi":"10.1007/s00134-025-08075-w","DOIUrl":"https://doi.org/10.1007/s00134-025-08075-w","url":null,"abstract":"","PeriodicalId":13665,"journal":{"name":"Intensive Care Medicine","volume":"90 1","pages":""},"PeriodicalIF":38.9,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144819642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ICU venous thromboembolism prophylaxis: revisiting external validity, vulnerable subgroups, and diagnostic standards, with future directions. ICU静脉血栓栓塞预防:重新审视外部有效性,易感亚群和诊断标准,与未来的方向。
IF 38.9 1区 医学
Intensive Care Medicine Pub Date : 2025-08-12 DOI: 10.1007/s00134-025-08077-8
Jianmin Qu
{"title":"ICU venous thromboembolism prophylaxis: revisiting external validity, vulnerable subgroups, and diagnostic standards, with future directions.","authors":"Jianmin Qu","doi":"10.1007/s00134-025-08077-8","DOIUrl":"https://doi.org/10.1007/s00134-025-08077-8","url":null,"abstract":"","PeriodicalId":13665,"journal":{"name":"Intensive Care Medicine","volume":"16 1","pages":""},"PeriodicalIF":38.9,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144819641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0.3 mg Melatonin: still too much? 0.3毫克褪黑素:还是太多?
IF 38.9 1区 医学
Intensive Care Medicine Pub Date : 2025-08-07 DOI: 10.1007/s00134-025-08073-y
Sulong Zheng
{"title":"0.3 mg Melatonin: still too much?","authors":"Sulong Zheng","doi":"10.1007/s00134-025-08073-y","DOIUrl":"https://doi.org/10.1007/s00134-025-08073-y","url":null,"abstract":"","PeriodicalId":13665,"journal":{"name":"Intensive Care Medicine","volume":"36 1","pages":""},"PeriodicalIF":38.9,"publicationDate":"2025-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144792129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信